# A Study to Decrease Suicidal Thinking Using Ketamine

> **NCT02418702** · PHASE3 · WITHDRAWN · sponsor: **United States Naval Medical Center, San Diego**

## Conditions studied

- Depression
- Suicide

## Interventions

- **DRUG:** 0.2 mg/kg ketamine
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT02418702
- **Lead sponsor:** United States Naval Medical Center, San Diego
- **Sponsor class:** FED
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-08
- **Primary completion:** 2016-08
- **Final completion:** 2017-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI no longer at facility.
- **Last updated:** 2019-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02418702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02418702, "A Study to Decrease Suicidal Thinking Using Ketamine". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02418702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*